alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**Exhibit 99.2
**$40,000,000 City of Petersburg, Indiana Pollution Control Refunding Revenue Bonds Adjustable Rate Tender Securities (ARTS)****SM****, Series 1995B (Indianapolis Power & Light Company Project)**

**AMENDMENT OF REMARKETING AGREEMENT**

This Amendment of Remarketing Agreement is made and entered into as of July10, 2008, by and between Indianapolis Power & Light Company (the “Company”) andJ.P. MORGAN SECURITIES, INC. (the “Remarketing Agent”), in order to amend theRemarketing Agreement entered into as of September 30, 1997, (the “OriginalRemarketing Agreement”), by and between the Company and the Remarketing Agentwith respect to the above-referenced bonds (the “Bonds”). 

Notwithstanding the provisions of Section 8 of the Original RemarketingAgreement, the Company agrees that if the credit agreement or facility providingliquidity for the Bonds has been terminated or suspended, the Company will notremove the Remarketing Agent without the prior written consent of theRemarketing Agent, unless concurrently with the removal of the RemarketingAgent, all Bonds owned by the Remarketing Agent in its individual capacity arepurchased from the Remarketing Agent at a price of par. 

The Original Remarketing Agreement is in all other respects ratified andconfirmed. 

J.P. MORGAN SECURITIES INC., as Remarketing Agent 

By:____________________________________ Authorized Signatory 

INDIANAPOLIS POWER & LIGHT COMPANY 

By:____________________________________ Authorized Signatory  

AMBAC INDEMNITY CORPORATION (if required)

By: N/A_________________________________ Authorized Signatory**
Exhibit 31.2


CERTIFICATION PURSUANT TO


RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,


AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002


I, Stephan Kuppenheimer, Chief Financial Officer of Blackstone Private Credit Fund, certify that:


1. I have reviewed this annual report on Form 10-K of Blackstone Private Credit Fund (the “registrant”);


2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;


3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the registrant as of, and for, the periods presented in this report;


4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:


(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;


(b) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


(c) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and


5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of trustees (or persons performing the equivalent function):


(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and


(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Date: March 9, 2022By:/s/ Stephan KuppenheimerStephan KuppenheimerChief Financial Officer
[Federal Register Volume 74, Number 182 (Tuesday, September 22, 2009)]
[Notices]
[Page 48261]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-22729]


-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. ER09-1655-000]


Fowler Ridge II Wind Farm, LLC; Supplemental Notice That Initial 
Market-Based Rate Filing Includes Request for Blanket Section 204 
Authorization

September 10, 2009.
    This is a supplemental notice in the above-referenced proceeding of 
Fowler Ridge II Wind Farm, LLC's application for market-based rate 
authority, with an accompanying rate tariff, noting that such 
application includes a request for blanket authorization, under 18 CFR 
Part 34, of future issuances of securities and assumptions of 
liability.
    Any person desiring to intervene or to protest should file with the 
Federal Energy Regulatory Commission, 888 First Street, NE., 
Washington, DC 20426, in accordance with Rules 211 and 214 of the 
Commission's Rules of Practice and Procedure (18 CFR 385.211 and 
385.214). Anyone filing a motion to intervene or protest must serve a 
copy of that document on the Applicant.
    Notice is hereby given that the deadline for filing protests with 
regard to the applicant's request for blanket authorization, under 18 
CFR Part 34, of future issuances of securities and assumptions of 
liability, is September 29, 2009.
    The Commission encourages electronic submission of protests and 
interventions in lieu of paper, using the FERC Online links at http://www.ferc.gov. To facilitate electronic service, persons with Internet 
access who will eFile a document and/or be listed as a contact for an 
intervenor must create and validate an eRegistration account using the 
eRegistration link. Select the eFiling link to log on and submit the 
intervention or protests.
    Persons unable to file electronically should submit an original and 
14 copies of the intervention or protest to the Federal Energy 
Regulatory Commission, 888 First St. NE., Washington, DC 20426.
    The filings in the above-referenced proceeding are accessible in 
the Commission's eLibrary system by clicking on the appropriate link in 
the above list. They are also available for review in the Commission's 
Public Reference Room in Washington, DC. There is an eSubscription link 
on the Web site that enables subscribers to receive e-mail notification 
when a document is added to a subscribed dockets(s). For assistance 
with any FERC Online service, please e-mail <a href="/cdn-cgi/l/email-protection#f7b1b2a5b4b8999b9e9992a4828787988583b791928594d9909881"><span class="__cf_email__" data-cfemail="7b3d3e293834151712151e280e0b0b14090f3b1d1e0918551c140d">[email protected]</span></a>. 
or call (866) 208-3676 (toll free). For TTY, call (202) 502-8659.

Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. E9-22729 Filed 9-21-09; 8:45 am]
BILLING CODE 6717-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
§ 9.10 Occupational Health and Safety Program (OHSP) and biosafety requirements. ( a ) *How are employee Occupational Health and Safety Program risks and concerns addressed?* The sanctuary shall assure that an Occupational Health and Safety Program (OHSP) is developed and implemented in accordance with current veterinary medical practices and the guidelines and standards found in the *Guide* (incorporated by reference, see paragraph (a) of section 9.4);
( b ) *How are biosafety concerns addressed?* The sanctuary shall institute and administer an effective biosafety program that addresses the biosafety hazards at that particular site. The program shall include identifying biohazards, outlining practices and procedures to be followed, providing personal safety equipment or protective clothing and equipment, and establishing a description of the facility requirements for working with hazardous agents or materials. Policies and procedures must be implemented to avoid exposure to environmental and animal hazards. Biosafety must be included in the training program for all Sanctuary employees. In establishing a program, the Sanctuary must use current accepted practices and publications prepared by the CDC, NIH, and professional societies specializing in biosafety. The input and guidance of personnel trained or experienced in biosafety are essential. Complete records of both clinical and experimental agent exposure must accompany each chimpanzee sent to the sanctuary. The donating facility must also provide recent testing (for example, serology, virus culture, histology) so that the sanctuary staff is fully aware of the health condition of the arriving chimpanzee. The records may be created and retained in electronic form.
```

[Congressional Bills 110th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2089 Enrolled Bill (ENR)]

:\HSEENR\h2089--enr.xml [file 1 of 1]

        H.R.2089

                       One Hundred Tenth Congress

                                 of the

                        United States of America

                          AT THE FIRST SESSION

          Begun and held at the City of Washington on Thursday,
            the fourth day of January, two thousand and seven

                                 An Act

 
To designate the facility of the United States Postal Service located at 
 701 Loyola Avenue in New Orleans, Louisiana, as the ``Louisiana Armed 
                    Services Veterans Post Office''.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,
SECTION 1. LOUISIANA ARMED SERVICES VETERANS POST OFFICE.
    (a) Designation.--The facility of the United States Postal Service 
located at 701 Loyola Avenue in New Orleans, Louisiana, shall be known 
and designated as the ``Louisiana Armed Services Veterans Post 
Office''.
    (b) References.--Any reference in a law, map, regulation, document, 
paper, or other record of the United States to the facility referred to 
in subsection (a) shall be deemed to be a reference to the ``Louisiana 
Armed Services Veterans Post Office''.

                               Speaker of the House of Representatives.

                            Vice President of the United States and    
                                               President of the Senate.
```
###### Editorial Note on Part 1

#### Editorial Notes:

1. In Patent and Trademark Office publications and usage the part number is omitted from the numbers of §§ 1.1 to 1.352 and the numbers to the right of the decimal point correspond with the respective rule numbers.

2. For nomenclature changes to part 1, see 68 FR 14335, Mar. 25, 2003; 87 FR 68904, Nov. 17, 2022.

#### § 1.804 Time of making an original deposit.

(a) Whenever a biological material is specifically identified in an application for patent as filed, an original deposit thereof may be made at any time before filing the application for patent or, subject to § 1.809, during pendency of the application for patent.

(b) When the original deposit is made after the effective filing date of an application for patent, the applicant must promptly submit a statement from a person in a position to corroborate the fact, stating that the biological material which is deposited is a biological material specifically identified in the application as filed.

[54 FR 34880, Aug. 22, 1989, as amended at 62 FR 53202, Oct. 10, 1997]

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 2 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 6 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 7 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 1 is placed in the separate grouping of parts pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 3 pertaining to both patents and trademarks is placed in the grouping pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 4 is placed in the separate grouping of parts pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 5 is placed in the separate grouping of parts pertaining to patents regulations.
§ 93.409 Settlement of research misconduct proceedings. ( a ) HHS may settle a research misconduct proceeding at any time it concludes that settlement is in the best interests of the Federal government and the public health or welfare.
( b ) Settlement agreements are publicly available, regardless of whether the ORI made a finding of research misconduct.
**
**EXHIBIT 23**

**DeGolyer and MacNaughton**

5001 Spring Valley Road 

Suite 800East 

Dallas, Texas 75244 

March 5, 2019 

Sabine Royalty Trust 

Simmons Bank, Trustee 

2911 Turtle Creek Blvd, Suite 850 

Dallas, Texas 75219 

Ladies and Gentlemen: 

We hereby consent to the inclusion of our report of third party dated February 25, 2019, containing our opinion on the estimated provedreserves and revenue, as of January 1, 2019, of certain royalty interests that Sabine Royalty Trust has represented it holds in the Annual Report on Form 10–K for the year ended December 31, 2018, of the Sabine Royalty Trust (the Form10–K) to be filed with the United States Securities and Exchange Commission. We also consent to the references to DeGolyer and MacNaughton under the heading “Properties—Reserves” in Item 2 and under the heading “SupplementalOil and Gas Information (Unaudited)—Reserve Quantities” in Item 8 of the Form 10–K. 

Very truly yours,

/s/ DeGolyer and MacNaughton 

DeGOLYER and MacNAUGHTON 

Texas Registered Engineering Firm F-716 
**
###### Editorial Note on Part 1

#### Editorial Notes:

1. In Patent and Trademark Office publications and usage the part number is omitted from the numbers of §§ 1.1 to 1.352 and the numbers to the right of the decimal point correspond with the respective rule numbers.

2. For nomenclature changes to part 1, see 68 FR 14335, Mar. 25, 2003; 87 FR 68904, Nov. 17, 2022.

#### § 1.31 Applicant may be represented by one or more patent practitioners or joint inventors.

An applicant for patent may file and prosecute the applicant's own case, or the applicant may give power of attorney so as to be represented by one or more patent practitioners or joint inventors, except that a juristic entity (*e.g.,* organizational assignee) must be represented by a patent practitioner even if the juristic entity is the applicant. The Office cannot aid in the selection of a patent practitioner.

[77 FR 48813, Aug. 14, 2012]

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 2 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 6 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 7 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 1 is placed in the separate grouping of parts pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 3 pertaining to both patents and trademarks is placed in the grouping pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 4 is placed in the separate grouping of parts pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 5 is placed in the separate grouping of parts pertaining to patents regulations.
§ 93.400 General statement of ORI authority. ( a ) *ORI review.* ORI may respond directly to any allegation of research misconduct at any time before, during, or after an institution's response to the matter. The ORI response may include, but is not limited to— ( 1 ) Conducting allegation assessments;
( 2 ) Determining independently if jurisdiction exists under this part in any matter;
( 3 ) Forwarding allegations of research misconduct to the appropriate institution or HHS component for inquiry or investigation;
( 4 ) Recommending that HHS should perform an inquiry or investigation or issue findings and taking all appropriate actions in response to the inquiry, investigation, or findings;
( 5 ) Notifying or requesting assistance and information from PHS funding components or other affected Federal and state offices and agencies or institutions;
( 6 ) Reviewing an institution's findings and process;
( 7 ) Making a finding of research misconduct; and
( 8 ) Proposing administrative actions to HHS.
( b ) *Requests for information.* ORI may request clarification or additional information, documentation, research records, or evidence from an institution or its members or other persons or sources to carry out ORI's review.
( c ) *HHS administrative actions.* ( 1 ) In response to a research misconduct proceeding, ORI may propose administrative actions against any person to the HHS and, upon HHS approval and final action in accordance with this part, implement the actions.
( 2 ) ORI may propose to the HHS debarring official that a person be suspended or debarred from receiving Federal funds and may propose to other appropriate PHS components the implementation of HHS administrative actions within the components' authorities.
( d ) *ORI assistance to institutions.* At any time, ORI may provide information, technical assistance, and procedural advice to institutional officials as needed regarding an institution's participation in research misconduct proceedings.
( e ) *Review of institutional assurances.* ORI may review institutional assurances and policies and procedures for compliance with this part.
( f ) *Institutional compliance.* ORI may make findings and impose HHS administrative actions related to an institution's compliance with this part and with its policies and procedures, including an institution's participation in research misconduct proceedings.
**U.S. Planting Seed Trade**

***September 1997***

**GeneralTrade Summary**

*Image: U.S. Planting Seed Exports byGroup****Image: U.S. Planting Seed Importsby Group*

U.S. planting seed exports duringJuly 1997, the first month of the 1997/98 Marketing Year (MY)totaled 68,697 metric tons valued at $43.8 million, declines of 4and 11 percent, respectively, over July 1996. Imports for themonth totaled 7,226 tons (9 percent below a year ago) valued at$22.3 million (2 percent above last year).

Despite substantial declines inboth volume and value, Mexico continued as the best export marketfor planting seeds in July, taking 3,778 tons valued at $9.9million, down 93 and 55 percent, respectively, from a yearearlier. Mexico accounted for 5 percent of total volume and 22percent of total value shipped during July.

Two of the top five markets havenever reached the top 15 before: Egypt and Morocco. Together,Egypt and Morocco accounted for 76 percent of total volume and 19percent of total value.

The export data show only 55 tonsof seeds other than wheat seed valued at $443,279 were shipped toEgypt in July. The unit value for those 55 tons exceeds $8.00 perkilogram while the unit value for the wheat seed portion is only$0.17 per kilogram; roughly half the usual unit value for wheatseed.

In the Morocco case, 60 tonsvalued at $46,641 were not wheat seed. The wheat seed was valuedat $0.12 per kilogram, well below the usual value. 

Canada led suppliers of plantingseeds to the United States in July, shipping 4,895 tons, valuedat $3.7 million, increases of 25 and 37 percent, respectively.The only surprises among the top five suppliers were Mexicorising to the second spot from somewhere in the second five andChina falling out of the top five.

A recent report from theAgricultural Minister-Counselor in Beijing, China indicates thata new regulation, titled "Circular on Regulations forApproval and Registration of Establishment of Foreign InvestedAgricultural Plant Seed Enterprises," went into effect onSeptember 15, 1997. The regulation requires that seed sold byforeign companies must be handled by approved joint ventures orcooperative companies. Wholly owned subsidiaries for foreigncompanies is prohibited. Controlling interest must be held by theChinese partner. In addition, if the company deals in grains,oilseeds and cotton the joint venture must be approved by theprovincial and central Governments and the U.S. company mustinvest at least $2.0 million. New companies dealing in all otherseeds must be approved at the Provincial level with a minimuminvestment by the U.S. partner of $500,000. This regulationplaces greater limits on foreign investment than previouslyexpected by industry and trading partners.

U.S. Planting Seed Export HighlightsU.S. Planting Seed Import Highlights

|                                      |
|-------------------------------------------|
| *Last modified: Wednesday, June 24, 1998* |
Re: HCFC IFR

Lee, Amanda I. to: Luke Hall-Jordan 05/18/2011 01:27 PM

Thanks Luke. I also checked with SBA and I agree that the RFA language should 

stay as is.

----- Original Message -----

From: Hall-Jordan.Luke@epamail.epa.gov <Hall-Jordan.Luke@epamail.epa.gov>

To: Lee, Amanda I.

Cc: mcconkey.diane@epamail.epa.gov <mcconkey.diane@epamail.epa.gov>

Sent: Wed May 18 13:21:07 2011

Subject: RE: HCFC IFR

Hi Amanda,

We've addressed all of your concerns and will work with the Office of

Policy to get the revised clean version uploaded to ROCIS. For the RFA

question, our OGC recommends we keep the text as is.

Best,

Luke

Luke Hall-Jordan

U.S. Environmental Protection Agency

1200 Pennsylvania Ave, NW (MC-6205J)

Washington, DC 20460

Office: 202-343-9591

Cell: 202-230-7589

From: "Lee, Amanda I." <Amanda_I._Lee@omb.eop.gov>

To: Luke Hall-Jordan/DC/USEPA/US@EPA

Date: 05/17/2011 12:22 PM

Subject: RE: HCFC IFR - Reg Agenda question

Thanks!

-----Original Message-----

From: Hall-Jordan.Luke@epamail.epa.gov [

mailto:Hall-Jordan.Luke@epamail.epa.gov]

Sent: Tuesday, May 17, 2011 12:02 PM

To: Lee, Amanda I.

Subject: HCFC IFR - Reg Agenda question

Hi Amanda,

The HCFC IFR should be coming out in the yet-to-be-published Spring 2011

Regulatory Agenda.

Talk to you soon,

Luke

Luke Hall-Jordan
U.S. Environmental Protection Agency

1200 Pennsylvania Ave, NW (MC-6205J)

Washington, DC 20460

Office: 202-343-9591

Cell: 202-230-7589